As of 2024-12-15, the EV/EBITDA ratio of Fulgent Genetics Inc (FLGT) is -8.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLGT's latest enterprise value is 541.77 mil USD. FLGT's TTM EBITDA according to its financial statements is -62.85 mil USD. Dividing these 2 quantities gives us the above FLGT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 13.1x | 11.1x |
| Forward P/E multiples | 9.4x - 11.4x | 9.9x |
| Fair Price | (20.03) - (21.51) | (19.70) |
| Upside | -202.3% - -209.9% | -200.6% |
| Date | EV/EBITDA |
| 2024-12-13 | -8.54 |
| 2024-12-12 | -8.94 |
| 2024-12-11 | -8.89 |
| 2024-12-10 | -8.94 |
| 2024-12-09 | -9.30 |
| 2024-12-06 | -8.87 |
| 2024-12-05 | -8.68 |
| 2024-12-04 | -8.92 |
| 2024-12-03 | -8.61 |
| 2024-12-02 | -8.62 |
| 2024-11-29 | -8.00 |
| 2024-11-27 | -7.89 |
| 2024-11-26 | -7.80 |
| 2024-11-25 | -8.01 |
| 2024-11-22 | -7.79 |
| 2024-11-21 | -7.34 |
| 2024-11-20 | -7.50 |
| 2024-11-19 | -7.36 |
| 2024-11-18 | -7.22 |
| 2024-11-15 | -7.52 |
| 2024-11-14 | -7.75 |
| 2024-11-13 | -8.06 |
| 2024-11-12 | -8.42 |
| 2024-11-11 | -8.84 |
| 2024-11-08 | -8.55 |
| 2024-11-07 | -9.81 |
| 2024-11-06 | -10.13 |
| 2024-11-05 | -9.81 |
| 2024-11-04 | -9.58 |
| 2024-11-01 | -9.61 |
| 2024-10-31 | -9.53 |
| 2024-10-30 | -8.96 |
| 2024-10-29 | -8.84 |
| 2024-10-28 | -8.79 |
| 2024-10-25 | -8.54 |
| 2024-10-24 | -8.41 |
| 2024-10-23 | -8.43 |
| 2024-10-22 | -8.63 |
| 2024-10-21 | -8.50 |
| 2024-10-18 | -8.71 |
| 2024-10-17 | -8.66 |
| 2024-10-16 | -8.87 |
| 2024-10-15 | -8.95 |
| 2024-10-14 | -9.00 |
| 2024-10-11 | -8.75 |
| 2024-10-10 | -8.82 |
| 2024-10-09 | -8.77 |
| 2024-10-08 | -9.08 |
| 2024-10-07 | -9.05 |
| 2024-10-04 | -9.26 |